Coral Drugs
New Delhi, India· Est.
India‑based API CMO delivering cGMP‑certified steroid, hormone and inhalation APIs worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based API CMO delivering cGMP‑certified steroid, hormone and inhalation APIs worldwide.
EndocrinologyOncologyRespiratoryAllergyDermatologyOphthalmologyVeterinary
Technology Platform
Advanced particle engineering and micronization combined with vertically integrated cGMP manufacturing enable precise particle sizing and scalable production of complex steroid, hormone and inhalation APIs.
Opportunities
Growing demand for high‑quality steroid and inhalation APIs, especially in emerging markets, and the company’s capacity to scale via its new high‑capacity block.
Risk Factors
Regulatory compliance risk, raw‑material price volatility, and intense competition from larger Indian API manufacturers.
Competitive Landscape
Competes with Indian API giants such as Sun Pharma, Aurobindo, and Divi’s Laboratories; differentiation lies in its vertical integration, particle‑engineering expertise, and cGMP‑certified facilities.